NIH Scientists and Collaborators Report Positive Results in Monkeys
One shot of an experimental vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector (called chimp adenovirus type 3 or ChAd3) protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation, report National Institutes of Health (NIH) scientists and their collaborators. The ability of the ChAd3 Ebola virus vaccine to elicit rapid protection in monkeys is notable as the world health community battles an ongoing Ebola virus disease outbreak in West Africa. While the protective effects of the single shot waned over time, two out of four inoculated animals were protected when challenged with Ebola virus 10 months after vaccination.
The research team, headed by Nancy J. Sullivan, Ph.D., of the National Institute of Allergy and Infectious Diseases Vaccine Research Center, also demonstrated increased levels of durable protection using an additional vaccine. They inoculated four macaques first with the ChAd3 Ebola vaccine, then 8 weeks later with a booster vaccine containing Ebola virus gene segments incorporated into a different vector (a poxvirus). Ten months after the initial inoculation, four out of four animals that received both shots were fully protected from infection with high doses of Ebola virus, demonstrating that the prime-boost regimen resulted in durable protection.
The Latest on: Ebola
via Google News
The Latest on: Ebola
- An ER doctor who survived Ebola shares the harrowing reality of the coronavirus pandemic and levels a stark warningon March 24, 2020 at 11:00 am
Dr. Craig Spencer, who's cared for Ebola patients and survived the disease himself, works at an ER in NYC. He explains why he fears the COVID-19 virus.
- Minister jailed for stealing ebola fundson March 24, 2020 at 10:00 am
A former health minister who led the fight to contain the ebola outbreak in central Africa has been jailed for five years for stealing funds earmarked to fight the disease.Oly Ilunga, 59, who was in ...
- Ebola-Scarred Sierra Leone Calls Year-Long Coronavirus Emergencyon March 24, 2020 at 9:07 am
Sierra Leone, one of the few countries yet to declare a case of coronavirus, introduced a 12-month state of emergency to deal with the disease.
- ER Doctor Who Survived Ebola Says He's More Afraid Of Coronavirus After Treating Patients in New York Cityon March 24, 2020 at 8:17 am
Craig Spencer, the director of global health at NewYork-Presbyterian/Columbia University Medical Center, described what it's like to treat coronavirus patients in New York City.
- NY Doc Who Survived Ebola: This Is Why I Fear COVID-19on March 24, 2020 at 3:36 am
Craig Spencer, the Columbia University Medical Center ER doctor who survived Ebola in 2014, has a very clear message for anyone who's listening -- he fears COVID-19, and the situation is getting worse ...
- NYC ER Doc Who Survived Ebola: 90% of My Patients Are Coronavirus Cases Nowon March 24, 2020 at 12:16 am
A New York City emergency room doctor -- who survived the Ebola virus five years ago -- says the city's hospitals are being all but overrun by the rush of COVID-19 cases. Craig Spencer is director of ...
- University of California researchers will test former Ebola drug as part of coronavirus clinical trialon March 23, 2020 at 6:00 pm
Now, researchers at UC Irvine have a shot at helping to find it. As part of a national clinical trial, the Orange County team of medical scientists are authorized to use the anti-viral drug remdesivir ...
- UCI researchers will test former Ebola drug as part of coronavirus clinical trialon March 23, 2020 at 1:00 pm
Everybody is hoping for a miracle drug to treat COVID-19, the disease caused by the infectious novel coronavirus. Now, researchers at UC Irvine have a shot at helping to find it. As part of a national ...
- UC Irvine researchers to test former Ebola drug in coronavirus clinical trialon March 23, 2020 at 11:25 am
Remdesivir was developed by Gilead Sciences, which has shut down its emergency access program for the drug due overwhelming demand.
- Can Drugs For Malaria, HIV, And Ebola Treat Covid-19? New WHO Trial Aims To Find Outon March 23, 2020 at 10:30 am
The World Health Organisation is launching a multinational clinical trial in which four existing drugs will be used to treat patients with covid-19. The project currently includes 10 countries and ...
via Bing News